Literature DB >> 9240768

Hypertension and serum Mg in the patients with diabetes and coronary heart disease.

N Nagase1.   

Abstract

Interrelations between hypertension (HT), ischemic heart disease (IHD) and diabetes mellitus (DM) were investigated in the diabetic subjects without IHD (DM group) or with IHD (DM + IHD group) and subjects with IHD (IHD group) which were not complicated with DM. 1. The incidence of hypertension of DM group, DM+IHD group and IHD group is 40, 54, 38% respectively. 2. The incidence of hyperlipidemia of DM group, DM + IHD group and IHD group is 55, 71, 56% respectively. 3. Serum Mg levels of DM (1.9 +/- 0.37 mg/dl), DM + IHD (1.8 +/- 0.23) and IHD (1.9 +/- 0.33) were significantly lower than that of normal control (2.3 +/- 0.32). 4. Serum Mg level of poorly controlled diabetic patients is lower than that of well controlled diabetic patients. These results suggested that Magnesium deficient state is one of the cause of insulin resistancy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9240768     DOI: 10.1291/hypres.19.supplementi_s65

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  4 in total

1.  Blood pressure reactions to insulin treatment in patients with type 2 diabetes.

Authors:  Sylvi U Persson
Journal:  Int J Angiol       Date:  2007

Review 2.  Dietary electrolytes and hypertension in the elderly.

Authors:  T Rosenthal; A Shamiss; E Holtzman
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 3.  Protective role of magnesium in cardiovascular diseases: a review.

Authors:  Sajal Chakraborti; Tapati Chakraborti; Malay Mandal; Amritlal Mandal; Sudip Das; Samarendranath Ghosh
Journal:  Mol Cell Biochem       Date:  2002-09       Impact factor: 3.396

4.  Improvement of cardiac ventricular function by magnesium treatment in chronic streptozotocin-induced diabetic rat heart.

Authors:  Hamida Aboalgasm; Morea Petersen; Asfree Gwanyanya
Journal:  Cardiovasc J Afr       Date:  2020-12-10       Impact factor: 1.167

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.